The International Society for Cell & Gene Therapy (ISCT) will host its 2026 Annual Meeting in May 2026, bringing together global leaders across academia, industry, clinical translation, regulatory bodies, and advanced therapy manufacturing. 

As one of the most influential events in the cell and gene therapy calendar, ISCT 2026 will once again provide a platform for scientific exchange, regulatory insight, and industry-shaping discussions.

The event will feature:

• A Translational Pathway Program with 25 plenary & concurrent sessions covering the state-of-the-art in cell and gene therapy. 
• A Roundtable Program offering 25 interactive expert-led sessions where researchers, clinicians, regulators and industry professionals collaborate on real-world challenges.

Why You Should Submit an Abstract?

Submitting an abstract is not only a chance to present your work – it’s also a gateway to networking with peers, meeting potential collaborators, and engaging with decision-makers in the therapeutic development ecosystem.

You’ll be able to:

• Present your work across the full cell and gene therapy translation pathway – from research to clinical and manufacturing.
• Gain visibility through oral, elevator-pitch or poster presentations.
• Have your accepted abstract published in a special supplemental edition of Cytotherapy – the official journal of ISCT.
• Compete for several scientific and early-career awards.
• Connect with a global, multidisciplinary audience and expand your professional network.

If you or your team plan to participate, submit your abstract before January 8, 2026 to ensure your work is included in the scientific program

Submit Abstract Here

Secure your place now and be part of the conversations shaping the future of advanced therapies.

Register to the Event